Risk of tuberculous infection in an indigenous population from Amazonia, Brazil

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 12, 2006, Pages 1354-1359

  Basta, P C ^a   Coimbra Jr , Carlos E A ^a   Camacho, L A B ^a   Santos, R V ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

BCG vaccine; Risk of infection; South American Indians; Tuberculin skin test; Tuberculosis

Indexed keywords

BCG VACCINE; TUBERCULIN;

ADULT; ARTICLE; BACTERIAL TRANSMISSION; BCG VACCINATION; BRAZIL; CHILD; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEALTH PROGRAM; HUMAN; INDIGENOUS PEOPLE; INFANT; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; PREVALENCE; PRIORITY JOURNAL; SCAR FORMATION; SKIN INDURATION; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; BCG VACCINE; BRAZIL; FEMALE; HUMANS; INDIANS, SOUTH AMERICAN; MALE; POPULATION GROUPS; PREVALENCE; RISK; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; VACCINATION;

EID: 33845523522     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Coimbra C E A Jr, Santos R V. Emerging health needs and epidemiological research in indigenous peoples in Brazil. In: Salzano F M, Hurtado A M, eds. Lost paradises and the ethics of research and publication. Oxford, UK: Oxford University Press, 2004; 89-109.
2. Hemming J. Amazon frontier: the defeat of the Brazilian Indians. Cambridge, MA, USA: Harvard University Press, 1987.
3. Baruzzi R G, Barros V L, Rodrigues D, Souza A L M, Pagliaro H. Saúde e doença em índios Panará após vinte e cinco anos de contato com o nosso mundo, com ênfase na ocorrência de tuberculose (Brasil Central). Cad Saude Publica 2001; 17: 407-412.
4. Garnelo L, Macedo G, Brandão L. Os povos indígenas e a construção das políticas de saúde no Brasil. Brasília, Brazil: Pan-American Health Organization, 2003.
5. Sousa A O, Salem J I, Lee F K, et al. An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci USA 1997; 94: 13227-13232.
6. Kritski A L, Ruffino-Netto A. Health sector reform in Brazil: impact on tuberculosis control. Int J Tuberc Lung Dis 2000; 4: 622-626.
7. Basta P C, Coimbra C E A Jr, Escobar A L, Santos R V, Alves L C C, Fonseca L S. Survey for tuberculosis in an indigenous population of Amazonia: the Surui of Rondônia, Brazil. Trans R Soc Trop Med Hyg 2006; 100: 579-585.
8. Escobar A L, Coimbra C E A, Jr, Camacho LAB, Portela M C. Tuberculose em populações indígenas de Rondônia, Amazônia, Brasil. Cad Saude Publica 2001; 17: 285-298.
9. Cauthen G M, Pio A, ten Dam H G. Annual risk of tuberculosis infection. Bull World Health Organ 2002; 80: 503-520.
10. Sutherland I. On the risk of infection. Bull Int Union Tuberc Lung Dis 1991; 66: 189-191.
11. Styblo K. Surveillance of tuberculosis. Int J Epidemiol 1976; 5: 63-68.
12. ten Dam H G, Hitze K L. Determining the prevalence of tuberculosis in populations with non-specific tuberculin sensitivity. Bull World Health Organ 1980; 58: 475-483.
13. Santos R V, Coimbra C E A Jr. On the (un)natural history of the Tupí-Mondé Indians: bioanthropology and change in the Brazilian Amazon. In: Goodman A H, Leatherman T L, eds. Building a new biocultural synthesis: political-economic perspectives on human biology. Ann Arbor, MI, USA: University of Michigan Press, 1988: 269-294.
14. Basta P C, Coimbra C E A Jr, Escobar A L, Santos R V. Aspectos epidemiológicos da tuberculose na população indígena Suruí, Amazônia, Brasil. Rev Soc Bras Med Trop 2004; 37: 338-342.
15. Barreto M L, Rodrigues L C, Cunha S S, et al. Design of the Brazilian BCG-REVAC trial against tuberculosis: a large, simple randomized community trial to evaluate the impact on tuberculosis of BCG revaccination at school age. Control Clin Trial 2002; 23: 540-553.
16. Camargos P A, Guimarães M D, Antunes C M. Risk assessment for acquiring meningitis tuberculosis among children not vaccinated with BCG: a case-control study. Int J Epidemiol 1988; 17: 193-197.
17. Wünsch-Filho V, Moncau J E C, Nakao N. Methodological considerations in case-control studies to evaluate BCG vaccine effectiveness. Int J Epidemiol 1993; 22: 149-155.
18. Smith K C, Starke J R. Bacille Calmette-Guérin vaccine. In: Plotkin A S, Orenstein W A, Offit P A, eds. Vaccines. 4th ed. Philadelphia, PA, USA and London, UK: W B Saunders, 2004: 129-209.
19. Pereira S M, Dourado I, Barreto M L, et al. Sensitivity and specificity of BCG scar reading in Brazil. Int J Tuberc Lung Dis 2001; 5: 1067-1070.
20. Arantes G R, Nardy S M C, Weiler R M G, Belluomini M, Nogueira P A. Estimativa do risco de infecção tuberculosa em populaç ões vacinadas pelo BCG. Rev Saude Publica 1992; 26: 96-107.
21. Rieder H L. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tubercle Lung Dis 1995; 76: 114-121.
22. Arnadotir T, Rieder H L, Trébucq A, Waaler H T. Guidelines for conducting tuberculin skin test survey in high prevalence countries. Tubercle Lung Dis 1996; 77 (Suppl): S1-S20.
23. Ruffino-Neto A. Tuberculose: a calamidade negligenciada. Rev Soc Bras Med Trop 2002; 35: 51-58.
24. Ministério da Saúde, Brasil. Vigilancia epidemiologica: tuberculose. Brazilia, Brasil: Programa Nacional de Controle da Tuberculose, Ministério da Saúde. http://portal.saude.gov.br/portal/svs/ visualizar_texto.cfm?idtxt=21445 Accessed September 2005.
25. Escobar A L, Coimbra C E A Jr, Camacho L A B, Santos R V. Tuberculin reactivity and tuberculosis epidemiology in the Pakaanova (Wari) Indians of Rondônia, south-western Brazilian Amazon. Int J Tuberc Lung Dis 2004; 8: 45-51.
26. van Crevel R, Doorninck D, Ams J, Tjon Kon Fat H, Vreden S S, Meer J M. Tuberculose onder Trio-indianen in Suriname. Ned Tijdschr Geneeskd 2004; 148: 425-429.
27. Basta P C, Camacho LAB. Teste tuberculínico na estimativa da prevalência de infecção por Mycobacterium tuberculosis em populações indígenas do continente americano: uma revisâo da literatura. Cad Saúde Publica 2006; 22: 245-254.
28. Hurtado A M, Hill K, Rosenblatt W, Bender J, Scharmen T. Longitudinal study of tuberculosis outcomes among immunologically naive Ache natives of Paraguay. Am J Phys Anthropol 2003; 121: 143-150.
29. Wijsmuller G. Relation between pre-vaccination and post-vaccination tuberculin sensitivity. Bull World Health Organ 1966; 35: 459-478.
30. Narain R. Interpretation of the repeat tuberculin test. Tubercle 1968; 49: 92-103.
31. Camacho L A B, Klein C H. Risco de infecção tuberculosa entre escolares com alta cobertura vacinal pelo BCG. Bol Oficina Sanit Panam 1990; 108: 101-112.
32. Murray C, Styblo K, Rouillon A. Tuberculosis. In: Jamison D T, Mosley W H, Measham A R, Bobadilla J L, eds. Disease control priorities in developing countries. New York, NY, USA: Oxford University Press, 1993: 233-259.